{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:56:00Z","timestamp":1792605360486,"version":"4.5.0"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cca.2024.119753","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T22:59:57Z","timestamp":1717023597000},"page":"119753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Metabolic biomarkers in irritable bowel syndrome diagnosis"],"prefix":"10.1016","volume":"560","author":[{"given":"Omid","family":"Vakili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Adibi Sedeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Pourfarzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cca.2024.119753_b0005","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jama.2020.22532","article-title":"Diagnosis and treatment of irritable bowel syndrome: a review","volume":"325","author":"Camilleri","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0010","doi-asserted-by":"crossref","first-page":"e14698","DOI":"10.1111\/nmo.14698","article-title":"A systematic review and meta-analysis of diet and nutrient intake in adults with irritable bowel syndrome","volume":"36","author":"Veraza","year":"2024","journal-title":"Neurogastroenterol Motil."},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0015","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/j.gastro.2023.08.010","article-title":"Prevalence and burden of illness of rome iv irritable bowel syndrome in the united states: results from a nationwide cross-sectional study","volume":"165","author":"Almario","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018.","volume":"156","author":"Peery","year":"2019","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cca.2024.119753_b0030","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S2468-1253(20)30217-X","article-title":"Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis","volume":"5","author":"Oka","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"26","key":"10.1016\/j.cca.2024.119753_b0035","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.3748\/wjg.v29.i26.4120","article-title":"Irritable bowel syndrome: epidemiology, overlap disorders, pathophysiology and treatment","volume":"29","author":"Huang","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.cca.2024.119753_b0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","article-title":"Global burden of irritable bowel syndrome: trends, predictions and risk factors","volume":"17","author":"Black","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2024.119753_b0045","article-title":"Healthcare utilization patterns: irritable bowel syndrome, inflammatory bowel disease, and gastroesophageal reflux disease","volume":"1","author":"Koloski","year":"2024","journal-title":"Dig. Dis. Sci."},{"issue":"37","key":"10.1016\/j.cca.2024.119753_b0050","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.3748\/wjg.v18.i37.5151","article-title":"Irritable bowel syndrome: diagnosis and pathogenesis","volume":"18","author":"El-Salhy","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.cca.2024.119753_b0055","doi-asserted-by":"crossref","first-page":"e13957","DOI":"10.1111\/nmo.13957","article-title":"Irritable bowel syndrome: straightening the road from the Rome criteria","volume":"32","author":"Camilleri","year":"2020","journal-title":"Neurogastroenterol Motil."},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0060","doi-asserted-by":"crossref","first-page":"e14579","DOI":"10.1111\/nmo.14579","article-title":"Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions","volume":"35","author":"Ghoshal","year":"2023","journal-title":"Neurogastroenterol Motil."},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0065","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/j.gastro.2004.12.006","article-title":"A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator","volume":"128","author":"Drossman","year":"2005","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4292\/wjgpt.v4.i4.97","article-title":"Metabolomics as a diagnostic tool in gastroenterology","volume":"4","author":"De Preter","year":"2013","journal-title":"World J. Gastrointest. Pharmacol. Therapeutics."},{"key":"10.1016\/j.cca.2024.119753_b0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40168-015-0139-9","article-title":"Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome","volume":"3","author":"Shankar","year":"2015","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/apt.13654","article-title":"Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach","volume":"44","author":"Baranska","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0085","first-page":"512","article-title":"Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome","volume":"22","author":"Tana","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0090","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/apt.15141","article-title":"Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers","volume":"49","author":"Keshteli","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4251\/wjgo.v8.i5.459","article-title":"Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: a clinical review","volume":"8","author":"Sarosiek","year":"2016","journal-title":"World J. Gastrointest. Oncol."},{"issue":"9","key":"10.1016\/j.cca.2024.119753_b0100","doi-asserted-by":"crossref","first-page":"e73076","DOI":"10.1371\/journal.pone.0073076","article-title":"The human urine metabolome","volume":"8","author":"Bouatra","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0105","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0110","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2024.119753_b0115","unstructured":"W. Thompson, Functional bowel disorders and functional abdominal pain. The functional gastrointestinal disorders: diagnosis, pathophysiology and treatment: a multinational consensus (1994) 115\u2013173."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cgh.2019.10.004","article-title":"Benefits and pitfalls of change from Rome III to Rome IV criteria for irritable bowel syndrome and fecal incontinence","volume":"18","author":"Lin","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.cca.2024.119753_b0125","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ajg.2016.308","article-title":"Enhancing diagnostic performance of symptom-based criteria for irritable bowel syndrome by additional history and limited diagnostic evaluation","volume":"111","author":"Sood","year":"2016","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.21457","article-title":"Colorectal cancer screening for average-risk adults: 2018 guideline update from the American cancer society","volume":"68","author":"Wolf","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"23","key":"10.1016\/j.cca.2024.119753_b0135","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/jama.2016.3332","article-title":"Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force","volume":"315","author":"Lin","year":"2016","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.cca.2024.119753_b0140","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1001\/jama.2016.6828","article-title":"Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force","volume":"315","author":"Knudsen","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2036.2006.02768.x","article-title":"Safe amounts of gluten for patients with wheat allergy or coeliac disease","volume":"23","author":"Hischenhuber","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3748\/wjg.v28.i1.154","article-title":"Current guidelines for the management of celiac disease: a systematic review with comparative analysis","volume":"28","author":"Raiteri","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1586\/egh.09.66","article-title":"Old and new serological tests for celiac disease screening","volume":"4","author":"Volta","year":"2010","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0160","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jgh.13474","article-title":"Prevalence and clinical significance of IgA anti-tissue transglutaminase antibodies in patients with chronic liver disease","volume":"32","author":"Sood","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.cca.2024.119753_b0165","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/clinchem\/48.9.1546","article-title":"Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study","volume":"48","author":"Carroccio","year":"2002","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.cca.2024.119753_b0170","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/gut.52.11.1567","article-title":"Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency","volume":"52","author":"Korponay-Szab\u00f3","year":"2003","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MPG.0b013e31824703c7","article-title":"Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients","volume":"55","author":"Mozo","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0180","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/j.gastro.2020.08.061","article-title":"AGA clinical practice update on the evaluation and management of seronegative enteropathies: expert review","volume":"160","author":"Leonard","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","article-title":"European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease 2020","volume":"70","author":"Husby","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0190","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Al-Toma","year":"2019","journal-title":"Unit. Eur. Gastroenterol. J."},{"issue":"9","key":"10.1016\/j.cca.2024.119753_b0195","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/MCG.0000000000000919","article-title":"World gastroenterology organisation global guidelines: celiac disease February 2017","volume":"51","author":"Bai","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Offi. J. Am. College Gastroenterol. ACG."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0205","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2036.2005.02417.x","article-title":"Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet","volume":"21","author":"Granito","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.cca.2024.119753_b0210","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.cgh.2019.11.049","article-title":"Pretest and post-test probabilities of diagnoses of rectal evacuation disorders based on symptoms, rectal exam, and basic tests: a systematic review","volume":"18","author":"Brandler","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.cca.2024.119753_b0215","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cgh.2010.06.031","article-title":"Digital rectal examination is a useful tool for identifying patients with dyssynergia","volume":"8","author":"Tantiphlachiva","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0220","doi-asserted-by":"crossref","first-page":"e13510","DOI":"10.1111\/nmo.13510","article-title":"Audit of the diagnosis of rectal evacuation disorders in chronic constipation","volume":"31","author":"Chedid","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0225","doi-asserted-by":"crossref","first-page":"e13845","DOI":"10.1111\/nmo.13845","article-title":"Clinical presentation and characteristics of pelvic floor myofascial pain in patients presenting with constipation","volume":"32","author":"Liu","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"issue":"8","key":"10.1016\/j.cca.2024.119753_b0230","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/nmo.12586","article-title":"Altered viscerotopic cortical innervation in patients with irritable bowel syndrome","volume":"27","author":"Irimia","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"issue":"10","key":"10.1016\/j.cca.2024.119753_b0235","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.pain.2013.06.024","article-title":"Sex differences in emotion-related cognitive processes in irritable bowel syndrome and healthy control subjects","volume":"154","author":"Labus","year":"2013","journal-title":"Pain"},{"issue":"43","key":"10.1016\/j.cca.2024.119753_b0240","doi-asserted-by":"crossref","first-page":"14252","DOI":"10.1523\/JNEUROSCI.1683-14.2014","article-title":"Sex and disease-related alterations of anterior insula functional connectivity in chronic abdominal pain","volume":"34","author":"Hong","year":"2014","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.cca.2024.119753_b0245","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/apt.12319","article-title":"Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome","volume":"37","author":"Lowen","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0250","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/gast.2003.50103","article-title":"Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome","volume":"124","author":"Drossman","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0255","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5056\/jnm20209","article-title":"A resting-state functional magnetic resonance imaging study of whole-brain functional connectivity of voxel levels in patients with irritable bowel syndrome with depressive symptoms","volume":"27","author":"Li","year":"2021","journal-title":"J. Neurogastroenterol. Motil."},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0260","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1089\/neu.2010.1563","article-title":"Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice","volume":"28","author":"Han","year":"2011","journal-title":"J. Neurotrauma."},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0265","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/17474124.2017.1288096","article-title":"Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?","volume":"11","author":"Camilleri","year":"2017","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2016.466","article-title":"Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis","volume":"112","author":"Irvine","year":"2017","journal-title":"Am. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.cca.2024.119753_b0275","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/MCG.0000000000001414","article-title":"Development of a score to predict positive colonic histology in chronic diarrhea assessed in open-access colonoscopy","volume":"55","author":"Atieh","year":"2021","journal-title":"J. Clin. Gastroenterol."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0280","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.14309\/ajg.0000000000000637","article-title":"Fecal bile acid testing in assessing patients with chronic unexplained diarrhea: implications for healthcare utilization","volume":"115","author":"Vijayvargiya","year":"2020","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.cca.2024.119753_b0285","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/gutjnl-2019-320325","article-title":"Actionable biomarkers: the key to resolving disorders of gastrointestinal function","volume":"69","author":"Camilleri","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0290","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0295","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5056\/jnm16135","article-title":"Biomarkers of irritable bowel syndrome","volume":"23","author":"Kim","year":"2017","journal-title":"J. Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000516027","article-title":"Biomarkers in irritable bowel syndrome: biological rationale and diagnostic value","volume":"40","author":"Nakov","year":"2022","journal-title":"Dig. Dis."},{"issue":"8","key":"10.1016\/j.cca.2024.119753_b0305","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2036.2009.03975.x","article-title":"Use of serum biomarkers in a diagnostic test for irritable bowel syndrome","volume":"29","author":"Lembo","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"49","key":"10.1016\/j.cca.2024.119753_b0310","doi-asserted-by":"crossref","first-page":"48794","DOI":"10.1074\/jbc.M310166200","article-title":"Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle","volume":"278","author":"Ohama","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0315","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","article-title":"Immune activation in patients with irritable bowel syndrome","volume":"132","author":"Liebregts","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0320","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/gutjnl-2011-300265","article-title":"Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome","volume":"61","author":"Yu","year":"2012","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0325","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/apt.12608","article-title":"A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads","volume":"39","author":"Jones","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0330","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ajg.2013.120","article-title":"Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?","volume":"108","author":"Hughes","year":"2013","journal-title":"Offi. J. Am. College Gastroenterol. ACG."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0335","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/clinchem\/hvad051","article-title":"Fecal calprotectin in gastrointestinal disease","volume":"69","author":"Murray","year":"2023","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.cca.2024.119753_b0340","first-page":"1339","article-title":"Faecal calprotectin is a reliable non-invasive marker for assessment of intestinal inflammation in patients with irritable bowel syndrome","volume":"66","author":"Nakov","year":"2013","journal-title":"CR Acad. Bulg. Sci."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0345","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2036.2009.03937.x","article-title":"Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia","volume":"29","author":"Walker","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.cca.2024.119753_b0350","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2036.2010.04282.x","article-title":"Implications of eosinophilia in the normal duodenal biopsy\u2013an association with allergy and functional dyspepsia","volume":"31","author":"Walker","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0355","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/gut.2007.140210","article-title":"Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity","volume":"57","author":"Gecse","year":"2008","journal-title":"Gut"},{"issue":"1\u20132","key":"10.1016\/j.cca.2024.119753_b0360","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pain.2009.04.017","article-title":"Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice","volume":"144","author":"Annahazi","year":"2009","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.cca.2024.119753_b0365","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1365-2982.2008.01166.x","article-title":"Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients","volume":"20","author":"Schoepfer","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"issue":"11","key":"10.1016\/j.cca.2024.119753_b0370","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41577-022-00700-9","article-title":"Immune activation in irritable bowel syndrome: what is the evidence?","volume":"22","author":"Aguilera-Lizarraga","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0375","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.33579","article-title":"Activation of the mucosal immune system in irritable bowel syndrome","volume":"122","author":"Chadwick","year":"2002","journal-title":"Gastroenterology"},{"issue":"55","key":"10.1016\/j.cca.2024.119753_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17550","article-title":"Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation","volume":"17","author":"Waugh","year":"2013","journal-title":"Health Technol. Assess."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0385","doi-asserted-by":"crossref","first-page":"26420","DOI":"10.1038\/srep26420","article-title":"A novel biomarker panel for irritable bowel syndrome and the application in the general population","volume":"6","author":"Mujagic","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0390","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12325-018-0673-5","article-title":"A Review of microbiota and irritable bowel syndrome: future in therapies","volume":"35","author":"Rodino-Janeiro","year":"2018","journal-title":"Adv. Ther."},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0395","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.remnie.2019.02.008","article-title":"75Se-Homocholic acid taurine scintigraphy (75SeHCAT\u00ae), a standard benchmark test in bile acid malabsorption?","volume":"38","author":"Garc\u00eda","year":"2019","journal-title":"Revista Espa\u00f1ola De Medicina Nuclear e Imagen Molecular (English Edition)."},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0400","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/gutjnl-2020-321466","article-title":"Association between Brachyspira and irritable bowel syndrome with diarrhoea","volume":"70","author":"Jabbar","year":"2021","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.cca.2024.119753_b0405","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1136\/gutjnl-2015-309889","article-title":"Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis","volume":"65","author":"Valentin","year":"2016","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0410","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2036.2009.04081.x","article-title":"Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome","volume":"30","author":"Wedlake","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0415","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/apt.13065","article-title":"Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome","volume":"41","author":"Camilleri","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.cca.2024.119753_b0420","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1365-2982.2012.01953.x","article-title":"Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea","volume":"24","author":"Gracie","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"issue":"11","key":"10.1016\/j.cca.2024.119753_b0425","doi-asserted-by":"crossref","first-page":"C979","DOI":"10.1152\/ajpcell.00228.2014","article-title":"From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology","volume":"307","author":"Natarajan","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0430","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-016-0446-z","article-title":"Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?","volume":"16","author":"Farup","year":"2016","journal-title":"BMC Gastroenterol."},{"issue":"9","key":"10.1016\/j.cca.2024.119753_b0435","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1021\/pr2003598","article-title":"Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome","volume":"10","author":"Le Gall","year":"2011","journal-title":"J. Proteome. Res."},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0440","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/19490976.2016.1215805","article-title":"Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome","volume":"7","author":"Zeber-Lubecka","year":"2016","journal-title":"Gut Microbes"},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0445","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/gutjnl-2015-311339","article-title":"FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial","volume":"66","author":"McIntosh","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0450","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MCG.0b013e318207f76c","article-title":"Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome","volume":"45","author":"Hong","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0455","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ajg.2011.458","article-title":"Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms?","volume":"107","author":"Ohman","year":"2012","journal-title":"Am. J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.cca.2024.119753_b0460","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3109\/00365521.2010.503965","article-title":"Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome","volume":"45","author":"El-Salhy","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0465","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.15330","article-title":"Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome","volume":"50","author":"Ianiro","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0470","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/gutjnl-2019-320411","article-title":"Faecal microbial transplantation in IBS: ready for prime time?","volume":"69","author":"Barbara","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0475","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/jcp.30697","article-title":"Exosomal microRNAs and long noncoding RNAs: novel mediators of drug resistance in lung cancer","volume":"237","author":"Taghvimi","year":"2022","journal-title":"J. Cell Physiol."},{"issue":"8","key":"10.1016\/j.cca.2024.119753_b0480","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/cbf.3671","article-title":"microRNAs in female infertility: an overview","volume":"39","author":"Bahmyari","year":"2021","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.cca.2024.119753_b0485","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cca.2022.10.018","article-title":"Exosomal noncoding RNAs in prostate cancer","volume":"537","author":"Movahedpour","year":"2022","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.cca.2024.119753_b0490","doi-asserted-by":"crossref","first-page":"1152672","DOI":"10.3389\/fphar.2023.1152672","article-title":"The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms","volume":"14","author":"Rezaee","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0495","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5056\/jnm16044","article-title":"Dysregulated MicroRNA expression in irritable bowel syndrome","volume":"22","author":"Park","year":"2016","journal-title":"J. Neurogastroenterol Motil."},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0500","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s11033-021-07007-3","article-title":"Gastrointestinal cancer drug resistance: the role of exosomal miRNAs","volume":"49","author":"Salehi","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0505","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2015.11.102","article-title":"MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome","volume":"469","author":"Liao","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0510","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.gastro.2014.09.037","article-title":"MicroRNA 29 targets nuclear factor-kappaB-repressing factor and Claudin 1 to increase intestinal permeability","volume":"148","author":"Zhou","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0515","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.2009.181834","article-title":"MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome","volume":"59","author":"Zhou","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0520","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/gutjnl-2013-306464","article-title":"Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1","volume":"65","author":"Zhou","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0525","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.yexmp.2014.04.009","article-title":"Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome","volume":"96","author":"Fourie","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"19","key":"10.1016\/j.cca.2024.119753_b0530","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/hmg\/ddn195","article-title":"First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome","volume":"17","author":"Kapeller","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cca.2024.119753_b0535","unstructured":"I. Johnston The role of FGF19 in the diagnosis and pathophysiology of primary bile acid diarrhoea 2016 Imperial College London."},{"key":"10.1016\/j.cca.2024.119753_b0540","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6961783","article-title":"Altered intestinal microbiota with increased abundance of Prevotella is associated with high risk of diarrhea-predominant irritable bowel syndrome","volume":"2018","author":"Su","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"issue":"12","key":"10.1016\/j.cca.2024.119753_b0545","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/nmo.12670","article-title":"Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome","volume":"27","author":"Dlugosz","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0550","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11934-010-0151-3","article-title":"Metabolic profiling for the detection of bladder cancer","volume":"12","author":"Van","year":"2011","journal-title":"Curr. Urol. Rep."},{"issue":"31","key":"10.1016\/j.cca.2024.119753_b0555","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.0504921102","article-title":"Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease","volume":"102","author":"Borovecki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"11","key":"10.1016\/j.cca.2024.119753_b0560","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1002\/art.22954","article-title":"Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome","volume":"56","author":"Hu","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0565","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1470-2045(08)70038-X","article-title":"Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish bladder cancer study: a case\u2013control study","volume":"9","author":"Moore","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cca.2024.119753_b0570","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cca.2012.08.016","article-title":"Urine metabolomics","volume":"414","author":"Zhang","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2024.119753_b0575","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-7804-5_10","article-title":"Mass spectrometry-based metabolomics","volume":"1775","author":"Kim","year":"2018","journal-title":"Methods Mol Biol."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0580","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mas.20108","article-title":"Mass spectrometry-based metabolomics","volume":"26","author":"Dettmer","year":"2007","journal-title":"Mass Spectrom. Rev."},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0585","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mas.20306","article-title":"Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies","volume":"30","author":"Theodoridis","year":"2011","journal-title":"Mass Spectrom. Rev."},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0590","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Innovation: metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0595","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.aca.2009.11.063","article-title":"Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach","volume":"661","author":"Kumar","year":"2010","journal-title":"Anal. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0600","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mas.21455","article-title":"Mass spectrometric based approaches in urine metabolomics and biomarker discovery","volume":"36","author":"Khamis","year":"2017","journal-title":"Mass Spectrom. Rev."},{"issue":"Database issue","key":"10.1016\/j.cca.2024.119753_b0605","first-page":"D801","article-title":"HMDB 3.0\u2013the human metabolome database in 2013","volume":"41","author":"Wishart","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0610","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1039\/B906712B","article-title":"Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy","volume":"40","author":"Dunn","year":"2011","journal-title":"Chem. Soc. Rev."},{"issue":"18","key":"10.1016\/j.cca.2024.119753_b0615","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.3390\/ijms21186843","article-title":"Metabolomic approaches to study chemical exposure-related metabolism alterations in mammalian cell cultures","volume":"21","author":"Balcerczyk","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0620","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/bmc.3266","article-title":"HILIC-MS-based shotgun metabolomic profiling of maternal urine at 9\u201323 weeks of gestation\u2013establishing the baseline changes in the maternal metabolome","volume":"29","author":"Trivedi","year":"2015","journal-title":"Biomed. Chromatogr."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0625","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jat.1746","article-title":"Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics","volume":"32","author":"Kumar","year":"2012","journal-title":"J. Appl. Toxicol."},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0630","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/mnfr.201200571","article-title":"UPLC-QTOF\/MS metabolic profiling unveils urinary changes in humans after a whole grain rye versus refined wheat bread intervention","volume":"57","author":"Bondia-Pons","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0635","doi-asserted-by":"crossref","first-page":"e13884","DOI":"10.1111\/nmo.13884","article-title":"Application of metabolomics to the study of irritable bowel syndrome","volume":"32","author":"Bennet","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"issue":"9","key":"10.1016\/j.cca.2024.119753_b0640","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: a clinical review","volume":"313","author":"Chey","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cca.2024.119753_b0645","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrgastro.2014.127","article-title":"Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or'psychomarkers'?","volume":"11","author":"Sood","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0650","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/00365521.2010.533380","article-title":"Serum fatty acid profile in subjects with irritable bowel syndrome","volume":"46","author":"Solakivi","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0655","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s11306-012-0469-6","article-title":"Targeted metabolomics profiles are strongly correlated with nutritional patterns in women","volume":"9","author":"Menni","year":"2013","journal-title":"Metabolomics"},{"key":"10.1016\/j.cca.2024.119753_b0660","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.abb.2015.09.017","article-title":"A single night of sleep curtailment increases plasma acylcarnitines: novel insights in the relationship between sleep and insulin resistance","volume":"589","author":"van den Berg","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"issue":"29","key":"10.1016\/j.cca.2024.119753_b0665","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1073\/pnas.1402663111","article-title":"Effect of sleep deprivation on the human metabolome","volume":"111","author":"Davies","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0670","doi-asserted-by":"crossref","first-page":"e0133283","DOI":"10.1371\/journal.pone.0133283","article-title":"Risk of psychiatric disorders following irritable bowel syndrome: a nationwide population-based cohort study","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cca.2024.119753_b0675","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/nmo.12895","article-title":"Dietary patterns and prevalence of irritable bowel syndrome in Iranian adults","volume":"28","author":"Khayyatzadeh","year":"2016","journal-title":"Neurogastroenterol. Motil."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0680","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2982.2006.00771.x","article-title":"Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome","volume":"18","author":"Park","year":"2006","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0685","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.infbeh.2009.10.004","article-title":"Comorbid depression and anxiety effects on pregnancy and neonatal outcome","volume":"33","author":"Field","year":"2010","journal-title":"Infant. Behav. Dev."},{"issue":"Suppl 3(S3)","key":"10.1016\/j.cca.2024.119753_b0690","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1017\/S0007114510003946","article-title":"Colonic metabolites of berry polyphenols: the missing link to biological activity?","volume":"104","author":"Williamson","year":"2010","journal-title":"Br. J. Nutr."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0695","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1099800415594251","article-title":"Serum tryptophan metabolite levels during sleep in patients with and without irritable bowel syndrome (IBS)","volume":"18","author":"Heitkemper","year":"2016","journal-title":"Biol. Res. Nurs."},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0700","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","article-title":"Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome","volume":"3","author":"Dunlop","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0705","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/gutjnl-2015-309151","article-title":"The role of mast cells in functional GI disorders","volume":"65","author":"Wouters","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0710","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.gastro.2015.12.034","article-title":"Histamine receptor H1-mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome","volume":"150","author":"Wouters","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2024.119753_b0715","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819886425","article-title":"Mass spectrometry-based metabolomics for irritable bowel syndrome biomarkers","volume":"12","author":"Yu","year":"2019","journal-title":"Therap. Adv. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0720","first-page":"89","article-title":"Sex difference in irritable bowel syndrome: do gonadal hormones play a role?","volume":"17","author":"Mulak","year":"2010","journal-title":"Gastroenterologia Polska: Organ Polskiego Towarzystwa Gastroenterologii."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0725","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cns.12490","article-title":"Stress and the microbiota-gut-brain axis in visceral pain: relevance to irritable bowel syndrome","volume":"22","author":"Moloney","year":"2016","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0730","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/en.2006-0740","article-title":"Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior","volume":"148","author":"Coddington","year":"2007","journal-title":"Endocrinol."},{"issue":"12","key":"10.1016\/j.cca.2024.119753_b0735","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1471-0528.1998.tb10014.x","article-title":"Do gastrointestinal symptoms vary with the menstrual cycle?","volume":"105","author":"Moore","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.cca.2024.119753_b0740","first-page":"42","article-title":"Psychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"16","author":"Kyritsi","year":"2017","journal-title":"Hormones"},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0745","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11306-019-1543-0","article-title":"Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients","volume":"15","author":"Yamamoto","year":"2019","journal-title":"Metabolomics"},{"issue":"7183","key":"10.1016\/j.cca.2024.119753_b0750","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.318.7183.565","article-title":"Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study","volume":"318","author":"Rodriguez","year":"1999","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0755","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gut.47.6.804","article-title":"Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acuteCampylobacter enteritis and in post-dysenteric irritable bowel syndrome","volume":"47","author":"Spiller","year":"2000","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0760","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/gut.52.4.523","article-title":"Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome","volume":"52","author":"Gwee","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0765","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cgh.2006.11.025","article-title":"Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen","volume":"5","author":"Marshall","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.cca.2024.119753_b0770","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.3748\/wjg.v22.i7.2242","article-title":"Inflammation in irritable bowel syndrome: Myth or new treatment target?","volume":"22","author":"Sinagra","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.cca.2024.119753_b0775","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/S0021-9258(18)96001-1","article-title":"The isolation of identical hydroxylysyl glycosides from hydrolysates of soluble collagen and from human urine","volume":"242","author":"Cunningham","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2024.119753_b0780","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/bse0520113","article-title":"Lysine post-translational modifications of collagen","volume":"52","author":"Yamauchi","year":"2012","journal-title":"Essays. Biochem."},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0785","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2018.09.055","article-title":"Microbially produced imidazole propionate impairs insulin signaling through mTORC1","volume":"175","author":"Koh","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cca.2024.119753_b0790","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/bph.12989","article-title":"Histamine H(4) receptors in the gastrointestinal tract","volume":"172","author":"Deiteren","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.cca.2024.119753_b0795","doi-asserted-by":"crossref","first-page":"9454","DOI":"10.1074\/jbc.M111.311084","article-title":"Crystal structure of interleukin-21 receptor (IL-21R) bound to IL-21 reveals that sugar chain interacting with WSXWS motif is integral part of IL-21R","volume":"287","author":"Hamming","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2024.119753_b0800","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/978-4-431-54841-6_67","article-title":"C-mannosylation: modification on tryptophan in cellular proteins","author":"Ihara","year":"2015","journal-title":"Glycoscience: Biology and Medicine: Springer Japan"},{"issue":"12","key":"10.1016\/j.cca.2024.119753_b0805","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/jn\/137.12.2641","article-title":"Relationship of dimethylglycine, choline, and betaine with oxoproline in plasma of pregnant women and their newborn infants","volume":"137","author":"Friesen","year":"2007","journal-title":"J. Nutr."},{"issue":"23","key":"10.1016\/j.cca.2024.119753_b0810","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1002\/1873-3468.12461","article-title":"Choline and dimethylglycine produce superoxide\/hydrogen peroxide from the electron transport chain in liver mitochondria","volume":"590","author":"Mailloux","year":"2016","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.cca.2024.119753_b0815","first-page":"481","article-title":"Stimulation of the immune response by dimethylglycine, a nontoxic metabolite","volume":"115","author":"Reap","year":"1990","journal-title":"J. Lab. Clin. Med."},{"issue":"33","key":"10.1016\/j.cca.2024.119753_b0820","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice","volume":"103","author":"Dumas","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"8","key":"10.1016\/j.cca.2024.119753_b0825","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/ajg.2011.120","article-title":"Reduced hippocampal glutamate-glutamine levels in irritable bowel syndrome: preliminary findings using magnetic resonance spectroscopy","volume":"106","author":"Niddam","year":"2011","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.cca.2024.119753_b0830","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0835","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0840","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1097\/MIB.0000000000001010","article-title":"Damage of the mucus layer: the possible shared critical common cause for both inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)","volume":"23","author":"Qin","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"issue":"3","key":"10.1016\/j.cca.2024.119753_b0845","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/003655200750024191","article-title":"Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome","volume":"35","author":"Rodr\u00edguez","year":"2000","journal-title":"Scand. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cca.2024.119753_b0850","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.MIB.0000195391.49762.89","article-title":"Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health","volume":"12","author":"Farrokhyar","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0855","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MIB.0000000000001017","article-title":"Prevalence and impact of inflammatory bowel disease-irritable bowel syndrome on patient-reported outcomes in CCFA partners","volume":"23","author":"Abdalla","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.cca.2024.119753_b0860","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/apt.13636","article-title":"The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity","volume":"44","author":"Diederen","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.cca.2024.119753_b0865","first-page":"8","article-title":"Recent and potential developments in the analysis of urine: a review","volume":"684","author":"Ryan","year":"2011","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.cca.2024.119753_b0870","first-page":"77","article-title":"Challenges and opportunities in systems biology studies. systems biology","author":"Mediani","year":"2023","journal-title":"Metabolomics"},{"issue":"8","key":"10.1016\/j.cca.2024.119753_b0875","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/jcp.24002","article-title":"Challenges and opportunities of metabolomics","volume":"227","author":"Johnson","year":"2012","journal-title":"J. Cell Physiol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124020059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124020059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T03:09:23Z","timestamp":1718161763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124020059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":175,"alternative-id":["S0009898124020059"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119753","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic biomarkers in irritable bowel syndrome diagnosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119753"}}